ZNF468 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.89689996832732E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.19489999999856E-05 |
Normal-vs-Stage2 |
1.032650E-04 |
Normal-vs-Stage3 |
3.05179992388105E-10 |
Normal-vs-Stage4 |
5.79930004018792E-09 |
Stage1-vs-Stage2 |
5.023400E-01 |
Stage1-vs-Stage3 |
2.695900E-03 |
Stage1-vs-Stage4 |
5.818500E-03 |
Stage2-vs-Stage3 |
1.473770E-01 |
Stage2-vs-Stage4 |
1.790840E-01 |
Stage3-vs-Stage4 |
8.997600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.80689999815942E-08 |
Normal-vs-AfricanAmerican |
5.60329560528317E-13 |
Normal-vs-Asian |
3.893600E-01 |
Caucasian-vs-AfricanAmerican |
1.75459999995908E-06 |
Caucasian-vs-Asian |
3.118200E-01 |
AfricanAmerican-vs-Asian |
1.042020E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.88759999997234E-06 |
Normal-vs-Female |
3.42700001709773E-09 |
Male-vs-Female |
5.219900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.02400000046421E-07 |
Normal-vs-Age(41-60Yrs) |
1.80739999999791E-06 |
Normal-vs-Age(61-80Yrs) |
1.42789999824089E-08 |
Normal-vs-Age(81-100Yrs) |
1.826890E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.692400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.315180E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.603400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.900600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.351200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.98250000000333E-05 |
Normal-vs-Grade 2 |
3.20009999610349E-08 |
Normal-vs-Grade 3 |
1.46150000002176E-06 |
Normal-vs-Grade 4 |
9.51949630234594E-12 |
Grade 1-vs-Grade 2 |
4.152600E-01 |
Grade 1-vs-Grade 3 |
6.284000E-01 |
Grade 1-vs-Grade 4 |
1.506640E-01 |
Grade 2-vs-Grade 3 |
6.406400E-01 |
Grade 2-vs-Grade 4 |
1.019450E-04 |
Grade 3-vs-Grade 4 |
1.202870E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.55626999999159E-05 |
Normal-vs-ccB subtype |
1.174380E-04 |
ccA subtype-vs-ccB subtype |
8.486800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.40379999957752E-07 |
Normal-vs-N1 |
3.015800E-03 |
N0-vs-N1 |
5.869000E-01 |
|
|